<div id="subtitle">Bristol-Myers Squibb, after nutrition business sale, has new pure pharma focus, $8B for deals</div><div><p>Bristol-Myers Squibb Co., the world's No. 15 drugmaker by revenue, reports fourth-quarter earnings Thursday. The following is a summary of key developments and analyst opinion related to the period.</p ...

<div id="subtitle">Bristol-Myers Squibb cuts 2009 profit outlook following Mead Johnson holdings split</div><div><p>Drug developer Bristol-Myers Squibb Co. cut its 2009 profit outlook Wednesday after completing a split off of its Mead Johnson Nutrition Co. holdings.</p><p>The company now expects adjusted profit ...

<div><p>BOSTON (Reuters) - Bristol-Myers Squibb Co <BMY.N> lowered its 2009 outlook on Wednesday to reflect the completion of its spinoff of Mead Johnson Nutrition Co <MJN.N>.</p><p>The New York-based drug company said it would report Mead Johnson as ...

<div id="subtitle">Bristol-Myers Squibb says Mead Johnson stock offer was oversubscribed</div><div><p>Drugmaker Bristol-Myers Squibb Co. said Friday its offer to exchange shares of baby formula maker Mead Johnson Nutrition Co. for shares of its own stock was oversubscribed.</p><p>The company said it ...